Abstract
There is an increasing need for successfully managing the rapidly progressing posterior eye diseases such as age-related macular degeneration, diabetic retinopathy and glaucoma. Therefore the challenges of drug delivery to the posterior eye are compounded by growing number of new therapeutic entities and the need for chronic therapy. Currently, the intravitreal route is widely used to deliver drugs, but frequent administration of drugs via this route can lead to retinal detachment, endophthalmitis and increased intraocular pressure. Controlled delivery systems, such as implants and nanoparticles have been developed to overcome these issues, but they are not devoid of adverse effects. Periocular route is a promising alternative owing to the large surface area and the relatively high permeability of the sclera. Yet, the blood retinal barriers and efflux transporters hamper the transport of therapeutic entities to the retina. As such the efficient delivery of drugs to the posterior eye remains a major challenge facing the pharmaceutical scientist. This review discusses the barriers to posterior eye drug delivery and current strategies used to overcome these barriers.
Keywords: Implants, Intravitreal route, Iontophoresis, Microneedles, Posterior eye drug delivery, Transscleral route, Drug Delivery Systems, transscleral routes, transdermal delivery
Drug Delivery Letters
Title: Drug Delivery to the Posterior Segment of the Eye: Challenges and Opportunities
Volume: 1 Issue: 1
Author(s): T. R. Thrimawithana, S. Young, C. R. Bunt, C. R. Green and R. G. Alany
Affiliation:
Keywords: Implants, Intravitreal route, Iontophoresis, Microneedles, Posterior eye drug delivery, Transscleral route, Drug Delivery Systems, transscleral routes, transdermal delivery
Abstract: There is an increasing need for successfully managing the rapidly progressing posterior eye diseases such as age-related macular degeneration, diabetic retinopathy and glaucoma. Therefore the challenges of drug delivery to the posterior eye are compounded by growing number of new therapeutic entities and the need for chronic therapy. Currently, the intravitreal route is widely used to deliver drugs, but frequent administration of drugs via this route can lead to retinal detachment, endophthalmitis and increased intraocular pressure. Controlled delivery systems, such as implants and nanoparticles have been developed to overcome these issues, but they are not devoid of adverse effects. Periocular route is a promising alternative owing to the large surface area and the relatively high permeability of the sclera. Yet, the blood retinal barriers and efflux transporters hamper the transport of therapeutic entities to the retina. As such the efficient delivery of drugs to the posterior eye remains a major challenge facing the pharmaceutical scientist. This review discusses the barriers to posterior eye drug delivery and current strategies used to overcome these barriers.
Export Options
About this article
Cite this article as:
R. Thrimawithana T., Young S., R. Bunt C., R. Green C. and G. Alany R., Drug Delivery to the Posterior Segment of the Eye: Challenges and Opportunities, Drug Delivery Letters 2011; 1 (1) . https://dx.doi.org/10.2174/2210304x11101010040
DOI https://dx.doi.org/10.2174/2210304x11101010040 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Review of and Perspectives on the Toxicology of Graphene-based Materials
Current Drug Metabolism Diabetic Cardiovascular Disease – AMP-Activated Protein Kinase (AMPK) as a Therapeutic Target
Cardiovascular & Hematological Agents in Medicinal Chemistry CD36 as a Therapeutic Target for Endothelial Dysfunction in Stroke
Current Pharmaceutical Design Subthreshold Diode Micropulse Laser Photocoagulation (SDM) as Invisible Retinal Phototherapy for Diabetic Macular Edema: A Review
Current Diabetes Reviews Microcirculation of the Diabetic Foot
Current Pharmaceutical Design Glucocorticoids: Structure, Signaling and Molecular Mechanisms in the Treatment of Diabetic Retinopathy and Diabetic Macular Edema
Current Molecular Medicine Intravitreal Bevacizumab for Diabetic Retinopathy
Current Diabetes Reviews Targeting Heme Oxygenase-1 in Vascular Disease
Current Drug Targets An Updated Review for the Diabetic Wound Healing Systems
Current Drug Targets Therapeutic Angiogenesis: Recent and Future Prospects of Gene Therapy in Peripheral Artery Disease
Current Gene Therapy Endothelin-1 Signaling in Vascular Physiology and Pathophysiology
Current Vascular Pharmacology Urokinase-a Very Popular Cardiovascular Agent
Recent Patents on Cardiovascular Drug Discovery Anaemia in Diabetes: An Emerging Complication of Microvascular Disease
Current Diabetes Reviews Identifying S100B as a Biomarker and a Therapeutic Target For Brain Injury and Multiple Diseases
Current Medicinal Chemistry The Sleeping Beauty Transposon Vector System for Treatment of Rare Genetic Diseases: An Unrealized Hope?
Current Gene Therapy A Closer Look to Polyesters: Properties, Synthesis, Characterization, and Particle Drug Delivery Applications
Nanoscience & Nanotechnology-Asia Novel and Emerging Targeted Therapies of Colorectal Cancer
Current Clinical Pharmacology Hypereosinophilic Syndrome, Churg-Strauss Syndrome and Parasitic Diseases: Possible Links between Eosinophilia and Thrombosis
Current Vascular Pharmacology Anti-VEGF Drugs in Eye Diseases: Local Therapy with Potential Systemic Effects
Current Pharmaceutical Design Treatment of Chronic Peripheral Arterial Disease
Current Vascular Pharmacology